NASDAQ$IMCR

Immunocore Holdings plc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Reports in 3 weeks

Immunocore hasn't published Q2 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q1 2026

    Revenue
    $107M
    EPS
    $0.25
  • Year-ago · Q2 2024

    Q2 2024

    Revenue
    $75.4M
    EPS
    -$0.23
  • FY2025 consensus

    Analyst consensus

    Revenue
    $356M
    EPS
    -$1.21

Revenue & EPS history

Immunocore · Revenue · Quarterly

$107M

Q1 2026+13.6%vs Q1 2025
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports

Historical avg

-0.3%

Avg return

Earnings day

+0.9%

Avg return

5 days after

-1.2%

Avg return

30 days after

48%

10 / 21 earnings

Positive

+8.3%

Q3 2023

Best reaction

-11.0%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.6%+0.0%-2.1%
Q4 2025-4.8%-3.0%-12.6%
Q3 2025-3.2%+9.7%+21.5%
Q1 2025+6.3%+5.3%+32.8%
Q4 2024+5.3%-1.1%+1.3%
Q3 2024+4.0%+5.0%-4.5%
Q2 2024+0.8%+1.7%-9.5%
Q1 2024-1.9%-6.6%-31.7%
Q4 2023-4.6%-7.2%-7.7%
Q3 2023+8.3%+4.6%+15.8%
Q2 2023-3.3%-5.9%-12.7%
Q1 2023-1.5%+3.2%-4.6%
Q4 2022-4.9%-5.1%-9.9%
Q3 2022+2.9%+13.7%+9.3%
Q2 2022+1.6%+5.8%-13.5%
Q1 2022-11.0%+2.7%+1.4%
Q4 2021-0.7%+7.5%+37.7%
Q3 2021+0.4%-0.2%-21.3%
Q2 2021-4.9%-9.5%-1.4%
Q1 2021-1.5%-9.4%-5.3%
Q4 2020+0.1%+6.8%-7.1%
Q3 2020
Q2 2020
Q1 2020
Q4 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro